ZA967759B - Selectively functionalizable desdendrimers. - Google Patents

Selectively functionalizable desdendrimers.

Info

Publication number
ZA967759B
ZA967759B ZA9607759A ZA967759A ZA967759B ZA 967759 B ZA967759 B ZA 967759B ZA 9607759 A ZA9607759 A ZA 9607759A ZA 967759 A ZA967759 A ZA 967759A ZA 967759 B ZA967759 B ZA 967759B
Authority
ZA
South Africa
Prior art keywords
desdendrimers
functionalizable
selectively
dendra
polyoxaalkylene
Prior art date
Application number
ZA9607759A
Other languages
English (en)
Inventor
Luigia Gozzini
Monica Muttoni
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of ZA967759B publication Critical patent/ZA967759B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/16—Dendrimers and dendritic polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Graft Or Block Polymers (AREA)
  • Polyamides (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
ZA9607759A 1995-09-15 1996-09-13 Selectively functionalizable desdendrimers. ZA967759B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001929A IT1277596B1 (it) 1995-09-15 1995-09-15 Composti macromolecolari di tipo dendrimerico

Publications (1)

Publication Number Publication Date
ZA967759B true ZA967759B (en) 1998-03-13

Family

ID=11372253

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9607759A ZA967759B (en) 1995-09-15 1996-09-13 Selectively functionalizable desdendrimers.

Country Status (12)

Country Link
US (2) US5807971A (xx)
EP (1) EP0850262B1 (xx)
JP (1) JPH11514396A (xx)
KR (1) KR19990044595A (xx)
AT (1) ATE201425T1 (xx)
AU (1) AU717922B2 (xx)
CA (1) CA2231840A1 (xx)
DE (1) DE69612987T2 (xx)
IT (1) IT1277596B1 (xx)
NO (1) NO315658B1 (xx)
WO (1) WO1997010281A1 (xx)
ZA (1) ZA967759B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277596B1 (it) * 1995-09-15 1997-11-11 Bracco Spa Composti macromolecolari di tipo dendrimerico
US5962423A (en) * 1998-08-07 1999-10-05 The Governors Of The University Of Alberta Treatment of bacterial dysentery
US6310043B1 (en) 1998-08-07 2001-10-30 Governors Of The University Of Alberta Treatment of bacterial infections
EP1179026A4 (en) 1998-11-05 2003-04-02 Univ Illinois BRANCHED AND HYPERRAMIFIED POLYETHERIMIDES FROM STABLE MONOMERS A1BN, AB, AA AND BB AND AM TERMINAL HAIRDRESSING AGENTS
US6258896B1 (en) 1998-12-18 2001-07-10 3M Innovative Properties Company Dendritic polymer dispersants for hydrophobic particles in water-based systems
US6395804B1 (en) 1998-12-18 2002-05-28 3M Innovative Properties Company Polyelectrolyte dispersants for hydrophobic particles in water-based systems
US6262207B1 (en) 1998-12-18 2001-07-17 3M Innovative Properties Company ABN dispersants for hydrophobic particles in water-based systems
NZ517017A (en) 1999-07-29 2004-05-28 Epix Medical Inc Targeting multimeric imaging agents through multiocus binding and improving the efficacy of in vivo contrast agents
AU2223401A (en) * 1999-12-24 2001-07-09 Kyowa Hakko Kogyo Co. Ltd. Branched polyalkylene glycols
JP4680351B2 (ja) * 2000-07-05 2011-05-11 日本曹達株式会社 スターポリマー
US6630578B2 (en) * 2000-11-24 2003-10-07 Communications Research Laboratory, Independent Administrative Institution Thioether derivatives, their method for production and use
DE60236796D1 (de) 2001-01-30 2010-08-05 Kyowa Hakko Kirin Co Ltd Verzweigte polyalkylenglykole
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
DE10318584A1 (de) * 2003-04-24 2004-11-11 Basf Ag Hochverzweigte polymere Stabilisatoren
KR100612079B1 (ko) * 2003-10-09 2006-08-11 주식회사 엘지화학 방사형 다분지 고분자 및 이를 이용한 다공성 막
NZ550604A (en) 2004-04-20 2010-09-30 Dendritic Nanotechnologies Inc Dendritic polymers with enhanced amplification and interior functionality
US7985424B2 (en) 2004-04-20 2011-07-26 Dendritic Nanotechnologies Inc. Dendritic polymers with enhanced amplification and interior functionality
CA2598430C (en) * 2005-04-20 2011-10-25 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality
CA2698812A1 (en) * 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
EP2133064A1 (en) * 2008-06-10 2009-12-16 3M Innovative Properties Company Initiator system containing a diarylalkylamine derivate, hardenable composition and use thereof
US8841382B2 (en) * 2010-09-01 2014-09-23 Basf Se Hyperbranched polyethers/dendrimers for solubilzation of sparingly soluble active ingredients

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568737A (en) * 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4737550A (en) * 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4587329A (en) * 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4694064A (en) * 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer
US4857599A (en) * 1988-02-08 1989-08-15 The Dow Chemical Company Modified dense star polymers
US5041516A (en) * 1989-06-21 1991-08-20 Cornell Research Foundation, Inc. Dendritic molecules and method of production
US5530092A (en) * 1992-01-13 1996-06-25 Dsm N.V. Dendritic macromolecule and the preparation thereof
IT1270994B (it) * 1994-03-18 1997-05-26 Bracco Spa Macromolecole ramificate a struttura poliossialchilica e loro usi
IT1277596B1 (it) * 1995-09-15 1997-11-11 Bracco Spa Composti macromolecolari di tipo dendrimerico

Also Published As

Publication number Publication date
DE69612987D1 (de) 2001-06-28
US5994495A (en) 1999-11-30
NO981092D0 (no) 1998-03-12
EP0850262A1 (en) 1998-07-01
AU717922B2 (en) 2000-04-06
DE69612987T2 (de) 2001-10-18
JPH11514396A (ja) 1999-12-07
WO1997010281A1 (en) 1997-03-20
ATE201425T1 (de) 2001-06-15
EP0850262B1 (en) 2001-05-23
AU6988196A (en) 1997-04-01
ITMI951929A1 (it) 1997-03-15
IT1277596B1 (it) 1997-11-11
KR19990044595A (ko) 1999-06-25
US5807971A (en) 1998-09-15
NO981092L (no) 1998-03-12
ITMI951929A0 (it) 1995-09-15
CA2231840A1 (en) 1997-03-20
NO315658B1 (no) 2003-10-06

Similar Documents

Publication Publication Date Title
ZA967759B (en) Selectively functionalizable desdendrimers.
FR2778662B1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE68907397T2 (de) Flüssige photopolymerisierbare Zusammensetzung, viskoelastisches Produkt, erhalten aus dieser Zusammensetzung und Verfahren zur Herstellung dieses viskoelastischen Produktes.
ATE83927T1 (de) Thrombinzusammensetzung.
TNSN87033A1 (fr) TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES
MX9706069A (es) Nuevos inhibidores de la trombina.
ATE202940T1 (de) Mittel und methoden zur behandlung von plaque- krankheiten
BG103096A (en) Thrombin inhibitors
ATE349420T1 (de) Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung
HK1045149A1 (en) Process to separate 1,3-propanediol or glycerol, or a mixture thereof from a biological mixture.
MY115211A (en) Novel amino acid derivatives, their preparation and use
NO974504D0 (no) Fremgangsmåte for fremstilling av 1,1'-£1,4-fenylenbis(metylen)|-bis-1,4,8,11-tetraazacyklotetradecan
AU1436097A (en) Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
CA2207505A1 (en) Neurological drug screens
DE69633391D1 (de) KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT
ATE271394T1 (de) Hybride zusammensetzungen für intrazellulaire verabreichung
DE69609614D1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ATE258783T1 (de) Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren
DE69431267T2 (de) Neuartige Cyclodextrin-glukanotransferase, Verfahren zu ihrer Herstellung und Verfahren zur Herstellung von Cyclodexrin mittels dieser
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
BR9813281A (pt) Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso
DE69326050D1 (de) Verfahren zur Herstellung von 0,0'-Diacylweinsäureanhydrid und Verfahren zur Herstellung von 0,0'-Diacylweinsäure
TR199801102T2 (xx) Antineoplazmik peptitler
DE59603908D1 (de) Verfahren zur Herstellung von N',N'-disubstituierten 1,4-Diaminoanthrachinonen
FR2654429B1 (fr) Nouveaux derives du methyl-2-propionate de 3,3,5-trimethylcyclohexanol, leur procede de preparation ainsi que compositions therapeutiques les contenant.